Recombinant Macaca fascicularis 40S ribosomal protein S26 (RPS26)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have special requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specifics. All proteins are shipped with standard blue ice packs. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
RPS26; QflA-11339; 40S ribosomal protein S26
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-115
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)
Target Names
RPS26
Target Protein Sequence
TKKRRNNGR AKKGRGHVQP IRCTNCARCV PKDKAIKKFV IRNIVEAAAV RDISEASVFD AYVLPKLYVK LHYCVSCAIH SKVVRNRSRE ARKDRTPPPR FRPAGAAPRP PPKPM
Uniprot No.

Target Background

Database Links

KEGG: mcf:102115597

UniGene: Mfa.2450

Protein Families
Eukaryotic ribosomal protein eS26 family
Subcellular Location
Cytoplasm, cytosol. Cytoplasm. Rough endoplasmic reticulum.

Q&A

What is the evolutionary conservation pattern of RPS26 across primate species?

RPS26 is highly conserved across eukaryotic species, including primates. Research indicates that ribosomal proteins like RPS26 maintain significant sequence identity across related species. Similar to what has been observed in other organisms, where RPs26 homologs can share >90% sequence identity between related species, Macaca fascicularis RPS26 likely shares high sequence conservation with human and other primate RPS26 proteins . The characteristic eukaryotic Y62-K70 motif (62-YXXPKXYXK-70) is particularly well-conserved, as this region plays a crucial role in establishing connections between mRNA and the ribosomal protein .

What are the key structural domains and motifs in Macaca fascicularis RPS26?

Based on structural analysis of RPS26 proteins across species, Macaca fascicularis RPS26 likely contains:

  • The conserved Y62-K70 motif (62-YXXPKXYXK-70) that is characteristic of all eukaryotic RPS26 proteins

  • RNA-binding regions that facilitate interactions with ribosomal RNA

  • Regions involved in protein-protein interactions within the 40S ribosomal subunit

These structural elements are critical for its function in translation and ribosome assembly. Researchers should focus on these conserved regions when designing experiments to study RPS26 function or when creating mutations for structure-function analyses .

How does RPS26 contribute to ribosome assembly and function?

RPS26 serves as an essential structural component of the 40S ribosomal subunit. Studies suggest that it plays crucial roles in:

  • Ribosome biogenesis and assembly

  • mRNA binding during translation initiation

  • Maintaining the structural integrity of the small ribosomal subunit

  • Potentially regulating translation of specific mRNAs

Research on ribosomal proteins has demonstrated that they are essential for cell proliferation, differentiation, and growth . RPS26 specifically contributes to these processes through its role in the 40S subunit, where it helps establish the connection between mRNA and the ribosome via its conserved Y62-K70 motif .

What expression systems are most effective for producing recombinant Macaca fascicularis RPS26?

For optimal expression of recombinant Macaca fascicularis RPS26, consider these methodological approaches:

  • E. coli expression systems:

    • BL21(DE3) strain with pET vector systems for high-yield expression

    • Use of solubility tags (MBP, SUMO, or GST) to enhance soluble expression

    • Optimization of induction conditions: lower temperatures (16-18°C) and reduced IPTG concentrations (0.1-0.5 mM) to minimize inclusion body formation

  • Eukaryotic expression systems:

    • Insect cell/baculovirus systems for proper folding and potential post-translational modifications

    • Mammalian expression systems (HEK293, CHO cells) for studies requiring authentic mammalian processing

  • Cell-free expression systems:

    • Wheat germ or rabbit reticulocyte lysate systems for rapid screening of expression constructs

Each system has distinct advantages depending on downstream applications and required protein authenticity .

What purification strategies yield the highest purity and biological activity of recombinant RPS26?

A multi-step purification approach is recommended for obtaining high-purity, biologically active RPS26:

  • Initial capture:

    • Affinity chromatography using His-tag, GST-tag, or other fusion tags

    • For His-tagged constructs: IMAC using Ni-NTA or Co-NTA resins with imidazole gradient elution

  • Intermediate purification:

    • Ion exchange chromatography (typically cation exchange as RPS26 has a basic pI)

    • Tag cleavage using specific proteases (TEV, PreScission, or SUMO protease)

  • Polishing steps:

    • Size exclusion chromatography to remove aggregates and ensure homogeneity

    • Removal of endotoxin using specialized resins for cellular assays

  • Quality control methods:

    • SDS-PAGE and Western blotting to confirm identity and purity

    • Mass spectrometry for accurate mass determination and verification

    • Circular dichroism to assess secondary structure integrity

This systematic approach ensures both high purity and preserved functional activity of the recombinant protein .

How can researchers confirm the proper folding and functionality of purified recombinant RPS26?

To verify proper folding and functionality of recombinant Macaca fascicularis RPS26, employ these complementary methods:

  • Structural integrity assessment:

    • Circular dichroism (CD) spectroscopy to analyze secondary structure elements

    • Differential scanning fluorimetry (DSF) to determine thermal stability

    • Limited proteolysis to probe for properly folded domains resistant to digestion

  • Functional assays:

    • In vitro ribosome assembly assays using purified ribosomal components

    • RNA binding assays to verify interaction with ribosomal RNA

    • 40S subunit incorporation assays using ribosome-depleted cellular extracts

  • Interaction studies:

    • Pull-down assays with known binding partners

    • Surface plasmon resonance (SPR) to measure binding kinetics

    • Microscale thermophoresis (MST) for quantitative binding measurements

These methods collectively provide strong evidence for proper folding and biological activity of the purified protein .

What experimental approaches are most informative for studying RPS26's role in translation?

To investigate RPS26's role in translation, employ these methodological approaches:

  • Ribosome profiling:

    • Use high-throughput sequencing of ribosome-protected mRNA fragments

    • Compare wild-type vs. RPS26-depleted or mutant systems

    • Identify specific mRNAs whose translation is affected by RPS26 alterations

  • In vitro translation assays:

    • Reconstituted translation systems with or without RPS26

    • Reporter-based assays measuring translation efficiency

    • Effect of RPS26 mutations on translation fidelity and rate

  • Structural studies:

    • Cryo-EM analysis of ribosomes with wild-type vs. mutant RPS26

    • Cross-linking studies to map RPS26 interactions within the translation machinery

  • Cellular models:

    • CRISPR/Cas9-mediated engineering of RPS26 variants

    • Polysome profiling to assess global translation effects

    • Pulse-labeling experiments to measure protein synthesis rates

These complementary approaches provide a comprehensive view of RPS26's functional roles in translation .

How can researchers investigate RPS26 interactions with other ribosomal components?

To study RPS26 interactions within the ribosomal context:

  • Co-immunoprecipitation approaches:

    • Use tagged RPS26 to pull down interacting partners

    • Analyze complexes by mass spectrometry to identify novel interactions

    • Validate with reverse co-IP experiments

  • Crosslinking and mass spectrometry (XL-MS):

    • Apply chemical crosslinkers to stabilize transient interactions

    • Identify crosslinked peptides by mass spectrometry

    • Map interaction interfaces at amino acid resolution

  • Proximity labeling techniques:

    • BioID or APEX2 fusion proteins to identify proximal proteins in living cells

    • TurboID for rapid labeling of interaction neighborhoods

  • Fluorescence-based interaction assays:

    • FRET or BiFC to visualize interactions in cells

    • Single-molecule fluorescence to study dynamics of interactions

  • Structural biology approaches:

    • Cryo-EM reconstruction of ribosomal complexes

    • X-ray crystallography of RPS26 with binding partners

These methods provide complementary data on RPS26's interaction network within the ribosome and potentially beyond .

What are the current approaches for studying RPS26 mutations associated with Diamond-Blackfan anemia in primate models?

For investigating RPS26 mutations related to Diamond-Blackfan anemia (DBA) using primate models:

  • Cell-based models:

    • CRISPR/Cas9 engineering of mutations in Macaca fascicularis-derived cell lines

    • iPSC models differentiated into hematopoietic lineages

    • Analysis of ribosome biogenesis, p53 activation, and erythroid differentiation

  • Biochemical characterization:

    • Comparative studies of wild-type vs. mutant recombinant RPS26

    • In vitro ribosome assembly assays to identify defects

    • rRNA processing analysis to detect pre-rRNA accumulation patterns

  • Structural impact assessment:

    • Molecular dynamics simulations of mutation effects

    • Cryo-EM analysis of ribosomes with mutant RPS26

    • Mapping mutations to functional domains and interaction interfaces

  • Transcriptomic and translatomic analyses:

    • RNA-seq to identify differentially expressed genes

    • Ribosome profiling to detect translation defects

    • Integrated analysis to identify pathways affected by RPS26 mutations

These approaches provide insight into how RPS26 mutations contribute to DBA pathogenesis, with potential for therapeutic development .

How can CRISPR/Cas9 genome editing be optimized for studying RPS26 function in primate cell lines?

For optimal CRISPR/Cas9 editing of RPS26 in primate cell lines:

This methodological framework ensures robust genetic models for studying RPS26 function .

What are the emerging techniques for studying the extraribosomal functions of RPS26?

To investigate potential extraribosomal functions of RPS26:

  • Proximity-dependent biotinylation (BioID, TurboID):

    • Identify non-ribosomal protein interactions

    • Map RPS26 localization to non-ribosomal compartments

    • Compare interactomes of free vs. ribosome-bound RPS26

  • Single-cell approaches:

    • smFISH combined with immunofluorescence to track RPS26 and mRNA

    • Live-cell imaging with fluorescently tagged RPS26

    • Single-cell proteomics to identify cell-specific RPS26 associations

  • RNA immunoprecipitation techniques:

    • CLIP-seq to identify direct RNA interactions beyond rRNA

    • RIP-seq to map broader RNA associations

    • RNA-protein interaction networks through comprehensive analysis

  • Spatial proteomics:

    • Proximity labeling combined with subcellular fractionation

    • In situ protein localization in different cellular states

    • Tracking RPS26 dynamics during cellular stress

  • Functional genomics screens:

    • CRISPR activation/repression libraries targeting RPS26 pathways

    • Synthetic lethality screens to identify functional dependencies

    • Chemical-genetic interaction mapping

These emerging techniques provide new insights into the expanding roles of ribosomal proteins beyond translation .

What are the common challenges in expressing recombinant RPS26 and their solutions?

Researchers frequently encounter these challenges when working with recombinant RPS26:

ChallengePotential SolutionsImplementation Details
Insolubility in E. coli1. Fusion with solubility tags (MBP, SUMO, TrxA)
2. Low-temperature expression (16-18°C)
3. Co-expression with chaperones
- Use pMAL or pSUMO vector systems
- Reduce IPTG to 0.1-0.3 mM
- Co-transform with pGro7 (GroEL/ES)
Proteolytic degradation1. Add protease inhibitors throughout purification
2. Optimize buffer conditions
3. Reduce purification time
- Use EDTA-free protease inhibitor cocktail
- Include 5-10% glycerol in buffers
- Maintain samples at 4°C
Poor yield1. Optimize codon usage for expression host
2. Test multiple expression systems
3. Scale-up culture volume
- Use strain-specific codon optimization
- Compare bacterial, insect, and mammalian systems
- Implement high-density fermentation
Incorrect folding1. Try refolding from inclusion bodies
2. Switch to eukaryotic expression systems
3. Co-express with ribosomal assembly factors
- Use stepwise dialysis protocols
- Baculovirus or mammalian expression
- Include molecular chaperones
Aggregation during storage1. Optimize buffer components
2. Add stabilizing agents
3. Determine optimal storage conditions
- Test pH range 7.0-8.0
- Add 5-10% glycerol or 100-200 mM NaCl
- Compare -80°C storage vs. liquid nitrogen

Implementation of these solutions should be systematic, testing one variable at a time while monitoring protein quality .

How can researchers troubleshoot poor incorporation of RPS26 into 40S ribosomal subunits in reconstitution experiments?

When facing challenges with RPS26 incorporation into 40S subunits:

  • Verify protein quality:

    • Confirm structural integrity through circular dichroism

    • Assess RNA binding capability through electrophoretic mobility shift assays

    • Check for proper folding using limited proteolysis

  • Optimize reconstitution conditions:

    • Systematically vary salt concentrations (50-300 mM KCl)

    • Test different Mg²⁺ concentrations (5-20 mM)

    • Adjust pH conditions (pH 6.8-7.5)

    • Include molecular crowding agents (PEG, Ficoll)

  • Assembly order considerations:

    • Follow the hierarchical assembly pathway established for eukaryotic ribosomes

    • Ensure prerequisite proteins and rRNA are correctly assembled before RPS26 addition

    • Consider co-incorporation with interacting partners

  • Technical refinements:

    • Extend incubation times for complete incorporation

    • Implement step-wise temperature gradients (16°C → 30°C)

    • Add ribosome assembly factors or chaperones

  • Analytical approaches:

    • Use sucrose gradient analysis to quantify incorporation efficiency

    • Apply native gel electrophoresis to assess intermediate complexes

    • Implement mass spectrometry to verify protein stoichiometry

Systematic troubleshooting using these approaches typically resolves incorporation issues in reconstitution experiments .

What strategies can address experimental artifacts when studying RPS26 post-translational modifications?

To minimize artifacts when studying RPS26 post-translational modifications (PTMs):

  • Sample preparation optimization:

    • Rapid extraction in denaturing conditions to preserve labile PTMs

    • Addition of specific inhibitors (phosphatase, deubiquitinase, deacetylase inhibitors)

    • Use of specialized lysis buffers optimized for the PTM of interest

  • Enrichment strategies:

    • PTM-specific antibodies for immunoprecipitation

    • Metal affinity chromatography for phosphopeptides

    • Specialized resins for ubiquitinated or acetylated proteins

  • Mass spectrometry considerations:

    • Use multiple proteases to increase sequence coverage

    • Implement parallel reaction monitoring (PRM) for targeted PTM detection

    • Consider electron transfer dissociation (ETD) for labile modifications

  • Validation approaches:

    • Orthogonal detection methods (Western blot, ELISA)

    • Site-directed mutagenesis of modified residues

    • In vitro enzymatic assays to confirm modification sites

  • Quantification strategies:

    • Stable isotope labeling (SILAC, TMT) for accurate quantification

    • Label-free approaches with appropriate normalization

    • Inclusion of synthetic modified peptide standards

These methodological refinements minimize artifacts and ensure reliable characterization of RPS26 PTMs .

How should researchers interpret discrepancies between in vitro and cellular studies of RPS26 function?

When facing discrepancies between in vitro and cellular RPS26 studies:

  • Systematic comparison approach:

    • Create a detailed comparison table of experimental conditions

    • Identify key variables that differ between systems

    • Design bridging experiments that incrementally increase complexity

  • Context-dependent analysis:

    • Consider that RPS26 functions within a complex ribosomal environment

    • Evaluate the presence/absence of cofactors and interaction partners

    • Assess the impact of cellular compartmentalization

  • Quantitative reconciliation:

    • Measure kinetic parameters across both systems

    • Develop mathematical models to identify missing factors

    • Design experiments to test model predictions

  • Technical considerations:

    • Evaluate protein modifications present in cells but absent in recombinant proteins

    • Consider cellular regulation mechanisms not represented in vitro

    • Assess the impact of concentration differences between systems

  • Integrated interpretation framework:

    • Recognize that both approaches provide valid but complementary information

    • Use in vitro studies for mechanistic details and cellular studies for physiological relevance

    • Develop a unified model that accommodates findings from both approaches

This systematic approach helps resolve apparent contradictions and builds a more complete understanding of RPS26 function .

What experimental design principles maximize reproducibility in RPS26 research?

To ensure high reproducibility in RPS26 research:

  • Standardized protein production:

    • Maintain consistent expression systems and purification protocols

    • Implement batch-to-batch quality control measures

    • Establish minimum purity and activity specifications

  • Rigorous experimental controls:

    • Include positive and negative controls in every experiment

    • Implement biological and technical replicates with appropriate sample sizes

    • Use multiple methodological approaches to address the same question

  • Comprehensive documentation:

    • Record detailed protocols including all buffer compositions

    • Document all experimental conditions, including temperature and incubation times

    • Maintain detailed equipment settings and calibration records

  • Blinding and randomization:

    • Implement researcher blinding where appropriate

    • Randomize sample processing order

    • Use automated analysis workflows to reduce bias

  • Data management best practices:

    • Implement electronic laboratory notebooks

    • Establish data storage and backup protocols

    • Pre-register experimental designs and analysis plans

  • Statistical considerations:

    • Perform appropriate power analyses before experiments

    • Select suitable statistical tests based on data distribution

    • Adjust for multiple comparisons when necessary

These principles significantly improve the reproducibility and reliability of RPS26 research findings .

What are the emerging technologies that could revolutionize our understanding of RPS26 function?

Several cutting-edge technologies show particular promise for advancing RPS26 research:

  • Cryo-electron tomography:

    • Visualize ribosomes in their native cellular environment

    • Map RPS26 position and dynamics within functioning polysomes

    • Correlate structural states with functional outcomes

  • Computational approaches:

    • Molecular dynamics simulations of complete ribosomes

    • AI-based prediction of RPS26 interactions and functions

    • Systems biology modeling of ribosome assembly pathways

  • Single-molecule techniques:

    • FRET-based analysis of RPS26 dynamics during translation

    • Optical tweezers to measure forces during ribosome function

    • Zero-mode waveguides for real-time visualization of translation

  • Spatial transcriptomics integration:

    • Map location-specific translation involving RPS26

    • Correlate RPS26 variants with spatial protein synthesis patterns

    • Integrate with single-cell multi-omics data

  • In situ structural biology:

    • Cellular electron cryotomography of RPS26 in native context

    • Integrative structural modeling combining multiple data types

    • Correlative light and electron microscopy of RPS26 dynamics

These technologies promise to reveal unprecedented insights into RPS26 function within the complex cellular environment .

How might research on Macaca fascicularis RPS26 contribute to understanding human ribosomal pathologies?

Macaca fascicularis RPS26 research offers valuable insights into human ribosomal disorders through:

  • Translational disease modeling:

    • Creation of physiologically relevant primate models of Diamond-Blackfan anemia

    • Testing of therapeutic interventions in systems closely related to humans

    • Identification of species-specific differences that impact disease mechanisms

  • Comparative molecular analysis:

    • Detailed structural comparisons between human and macaque RPS26

    • Functional analysis of disease-associated mutations in both species

    • Evolutionary conservation assessment of pathogenic mechanisms

  • Therapeutic development pipeline:

    • Preclinical testing of ribosome-targeted therapies

    • Evaluation of gene therapy approaches for ribosomal protein deficiencies

    • Pharmacological screening in macaque cellular systems

  • Mechanistic insights from subtle differences:

    • Identification of sequence variations that alter susceptibility to disease

    • Analysis of species-specific regulatory mechanisms

    • Understanding of compensatory pathways that differ between species

This research provides a crucial bridge between fundamental molecular studies and clinical applications, potentially accelerating the development of treatments for human ribosomal disorders .

What fundamental principles should guide experimental design when working with recombinant RPS26?

When designing experiments with recombinant Macaca fascicularis RPS26, researchers should adhere to these guiding principles:

  • Structural integrity verification:

    • Always confirm proper folding before functional studies

    • Validate protein quality through multiple complementary methods

    • Consider the impact of tags and fusion partners on function

  • Contextual relevance:

    • Remember that RPS26 functions as part of a complex macromolecular machine

    • Design experiments that account for interaction partners

    • Consider both ribosomal and potential extraribosomal functions

  • Evolutionary perspective:

    • Leverage the high conservation of RPS26 for comparative studies

    • Use evolutionary analysis to identify functionally critical regions

    • Consider species-specific differences when extrapolating findings

  • Multidisciplinary approach:

    • Combine structural, biochemical, and cellular methods

    • Integrate computational and experimental approaches

    • Build collaborative teams with diverse expertise

  • Translational awareness:

    • Design studies with potential relevance to human disease

    • Consider how findings might contribute to therapeutic development

    • Maintain focus on mechanistic understanding that can inform clinical applications

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.